Mayo Foundation for Medical Education and Research;Sloan-Kettering Institute for Cancer Research;Sarentis Therapeutics, Inc.
发明人:
DENISE BARBUT,Gavril W. Pasternak,Elliott Richelson
申请号：
US14245720
公开号：
US20150080314A1
申请日:
2014.04.04
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Ocular analgesics for topical administration are described. The topical ocular analgesic includes a neo-tryptophan-containing neurotensin analog. The topical ocular analgesic may alternatively include a buffered salt solution, a local anesthetic solution, a tissue penetrating agent, and/or an opiate. The neo-tryptophan-containing neurotensin analog may be present in a dose of about 0.0005 to about 1.2 mg.
